scispace - formally typeset
G

Gabriel Lopez-Berestein

Researcher at University of Texas MD Anderson Cancer Center

Publications -  386
Citations -  27893

Gabriel Lopez-Berestein is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Ovarian cancer. The author has an hindex of 76, co-authored 367 publications receiving 23747 citations. Previous affiliations of Gabriel Lopez-Berestein include University of Texas at Austin & University of Texas System.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

MicroRNAs in body fluids—the mix of hormones and biomarkers

TL;DR: The role of fluid-expressedmiRNAs as reliable cancer biomarkers and treatment-response predictors as well as potential new patient selection criteria for clinical trials are discussed and the concept that miRNAs could function as hormones is explored.
Journal ArticleDOI

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

TL;DR: Chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model, and β-adrenergic activation of the cAMP–PKA signaling pathway is identified as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth.
Journal ArticleDOI

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

TL;DR: Insight is provided into the regulatory mechanisms involved in the deregulation of miRNAs in cancer cells and the tumor microenvironment and therapeutic intervention strategies to overcome this deregulation are discussed.